探讨常规凝血检验项目在异位妊娠大出血输血治疗疗效和预测中的作用监测

The role of routine coagulation test in the monitoring and prediction of hematopoietictreatment of ectopic pregnancy hemorrhage

目的 探讨常规凝血检验项目在异位妊娠大出血输血治疗疗效监测和预测中的作用.方法 选择2014 年1月-2015 年12月间,我院收治的,获得明确诊断的异位妊娠患者96 例作为研究对象,将其按照在输血治疗时是否发生不良反应分成两组,每组48例,分别定义为不良反应组和无不良反应组,对比两组检测结果.结果 输血后不良反应组FIB 水平较无不良反应组发生明显降低（P 〈 0.05）;不良反应组PT、TT、APTT 较无不良反应组明显升高（P 〈 0. 05）.结论 对常规凝血项目进行检测,对于防控异位妊娠输血治疗不良反应具有重要意义,值得关注并推广.

Objective To investigate the role of routine coagulation test in the monitoring and prediction of hematopoietictreatment of ectopic pregnancy hemorrhage. Methods A total of 96 patients with ectopic pregnancy were enrolled in ourstudy from January 2014 to December 2015. All subjects were divided into two groups （the adverse reaction group and nonadversereaction group） according to adverse reactions during transfusion therapy, 48 cases in each group. The test results oftwo groups were investigated. Results The level of FIB in the adverse reaction group was significantly lower than that in thenon-adverse reaction group （P〈0.05）. The levels of PT, TT, APTT of were significantly higher than those of the non-adversereaction group （P〈0.05）. Conclusion Conventional coagulation test is significance for the prevention and treatment of ectopicpregnancy transfusion treatment of adverse reactions. It has great clinical value.